TruaceTracing the truth around AITuesday, September 15, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,419 results
Show filters and sorting

AI gains · 788

68
GainHealth· Stable· Evidence: Moderate (1 source)

Plasma proteomics XGBoost models with SHAP-selected markers improved discrimination of prevalent osteoporosis and prediction of incident osteoporosis from baseline samples in UK Biobank.

Using UK Biobank plasma proteomics, researchers developed SPX-OP, an explainable machine-learning framework that separately models prevalent osteoporosis and incident osteoporosis with XGBoost and SHAP, then evaluates a combined marker panel for baseline stratification. By publication date 2026-09-01, both diagnostic and prognostic models showed robust discrimination, and a model using only SHAP-selected proteins outperformed full-proteome models.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%97

Updated Sep 1, 2026 · TRV-2026-0947

68
GainHealth· Stable· Evidence: Moderate (1 source)

Machine learning and related SMART technologies improved early diagnosis and monitoring of obesity by predicting metabolic risk and automating adipose tissue measurement, and were linked to meaningful weight loss after robotic bariatric procedures.

Published August 29, 2026, this narrative review in Advances in Therapy surveyed recent technologies used for obesity management, including machine learning risk prediction, convolutional neural networks for adipose tissue analysis, minimally invasive robotic bariatric surgery, virtual reality cue exposure therapy, and mobile tracking apps.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%97

Updated Aug 31, 2026 · TRV-2026-0941

68
GainHealth· Stable· Evidence: Moderate (1 source)

An integrated ligand-based machine learning and structure-based docking funnel screened 22,823 compounds and identified HY-18,623 as a potent dual CDK4/6 inhibitor with low-nanomolar IC50s.

Researchers built a virtual screening funnel that combined a Bayesian Ridge regressor trained on ChEMBL CDK4/6 inhibitor data with structure-based docking and molecular dynamics. The ML model using ECFP4 fingerprints achieved cross-validated R2 around 0.73 for CDK4 and 0.72 for CDK6 and was used to prioritize a 22,823-compound library down to three hits.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%97

Updated Aug 31, 2026 · TRV-2026-0940

68
GainCrime· Stable· Evidence: Moderate (1 source)

The integrated ML-based Yield Gap Vulnerability framework provides a data-driven decision-support tool that can support sustainable agricultural management, spatial planning and risk reduction by identifying vulnerability hotspots for region-specific measures in India.

Researchers developed a Yield Gap Vulnerability framework for India that integrates agricultural, hydrological, meteorological and socioeconomic indicators with observed yield gaps for rice, wheat, maize and millet at district level, using an integrated Machine Learning approach with XGBoost, Random Forest and Artificial Neural Network models.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%97

Updated Aug 31, 2026 · TRV-2026-0939

AI problems · 631

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

Pooled performance estimates were based predominantly on internal validation, with true external validation remaining sparse, limiting confidence in generalizability.

A systematic review and meta-analysis up to September 2025 synthesized 83 studies involving at least 136,840 patients to evaluate machine learning models predicting hematoma expansion, poor functional outcome, and mortality after spontaneous intracerebral hemorrhage. Pooled analyses found that models combining clinical and radiomics features achieved the highest discrimination, with C-indexes of 0.822, 0.850, and 0.860 respectively, largely from internal validation sets.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%91

Updated Aug 1, 2026 · TRV-2026-0611

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

Calibration assessment showed dataset shift, so absolute predicted probabilities should be interpreted cautiously and the model should not drive CSF diversion decisions alone without prospective validation.

Investigators developed and externally validated a machine learning model to stratify risk of postoperative hydrocephalus after posterior fossa tumor resection using data from 1,073 patients treated at five tertiary centers from 2013 to 2024. After screening 30 variables, they built a three-variable preoperative model using Evans index, tumor-fourth ventricle relationship, and preoperative CSF diversion status, with SVM showing AUC 0.877 in the external cohort.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%91

Updated Jul 31, 2026 · TRV-2026-0600

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

Rapid integration of AI/ML introduced interconnected ethical challenges around bias, accountability, privacy, and equity that affect patient safety and trust.

By July 2026, a narrative review of 127 peer-reviewed studies from 2015-2026 examined how AI and ML are being used in pharmaceutical research and healthcare. The review found the technologies enable large-scale biomedical data analysis and data-driven decision-making while simultaneously introducing interconnected ethical challenges.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 27, 2026 · TRV-2026-0578

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

Deployment of multimodal machine learning for AML transfusion management is limited by data privacy protection, data standardisation across platforms, and model interpretability for clinical adoption.

This peer-reviewed review published July 24, 2026 synthesized recent progress on machine learning models that integrate multimodal big data such as electronic health records, genomic and proteomic data to guide transfusion support for acute myeloid leukaemia, a highly heterogeneous malignancy where transfusion is essential.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 27, 2026 · TRV-2026-0577

Recomputed live from the record · Sep 15, 2026, 10:52 PM